Maryse Lapeyre Mestre (Maryse Lapeyre-Mestre, Maryse Lapeyre-Mester)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 53

Top Venues

Fundamental & clinical pharmacology

British journal of clinical pharmacology

CNS drugs

Pharmacoepidemiology and drug safety

Université Paul Sabatier Toulouse III

Université Bordeaux Segalen (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université Paul Sabatier Toulouse III Sep 01 1998

France

MCU-PH :: Pharmacologie Médicale et Clinique

Education History

Université Bordeaux Segalen

France

MSC :: ISPED

Université Paris-Sud Faculté de Médecine

France

MSC :: Epidemiologie

Publications

Anaïs Couret, Virginie Gardette, Axel Renoux, Maryse Lapeyre Mestre
Impact of modifications to antidementia drug reimbursement in France: Analysis of the FRA-DEM cohort. British journal of clinical pharmacology (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs 38 (9) (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs (2024)
Pauline Gandolfo, Thomas Soeiro, Élisabeth Jouve, Bruno Revol, Amélie Daveluy, Célian Bertin, Céline Eiden, Valérie Gibaja, Leila Chaouachi, Marie-Christine Pérault-Pochat, Cécile Chevallier, Aurélie Aquizérate, Reynald Le Boisselier, Louise Carton, Maryse Lapeyre Mestre, Elisabeth Frauger, Clémence Lacroix, Joëlle Micallef
Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network. Fundamental & clinical pharmacology (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs 38 (9) (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs 38 (9) (2024)
Yoann Zadro, Margaux Lafaurie, Marc Michel, Maryse Lapeyre Mestre, Guillaume Moulis
Risk of hospitalization with infection in adults with primary AIHA treated with rituximab: a French nationwide study. Blood advances (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs 38 (9) (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Correction to: Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs (2024)
Romain Barus, François Montastruc, Claire de Canecaude, Haleh Bagheri, Agnès Sommet, Maryse Lapeyre Mestre
Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study. Expert opinion on drug safety (2023)
Natasha Ollier, Marie-Léa Piel-Julian, Matthieu Mahevas, Jean-François Viallard, Thibault Comont, Stéphane Cheze, Sylvain Audia, Mikael Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre Mestre, Bertrand Godeau, Guillaume Moulis
Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents. Blood (2023)
Julien Maquet, Margaux Lafaurie, Marc Michel, Maryse Lapeyre Mestre, Guillaume Moulis
Drug-Induced Immune Hemolytic Anemia: Detection of New Signals and Risk Assessment in a Nationwide Cohort Study. Blood advances (2023)
Thomas Soeiro, Vincent Pradel, Maryse Lapeyre Mestre, Joëlle Micallef
Systematic assessment of non-medical use of prescription drugs using doctor-shopping indicators: A nationwide, repeated cross-sectional study. Addiction (Abingdon, England) (2023)
Marie Pajiep, Maryse Lapeyre Mestre, Fabien Despas
Drug-drug interactions of protein kinase inhibitors in chronic myeloid leukaemia patients: a study using the French health insurance database. Fundamental & clinical pharmacology (2023)
Amélie Daveluy, Michael Charles Bryan, Ghada Miremont-Salamé, Régis Lassalle, Clémentine Lacueille, Angela Grelaud, Marie Floccia, Françoise Haramburu, Maryse Lapeyre Mestre, Joëlle Micallef, Francesco Salvo
Analgesic switching in chronic users of dextropropoxyphene in France. Fundamental & clinical pharmacology (2023)
Justine Lavergne, Marion Debin, Thierry Blanchon, Vittoria Colizza, Lise Dassieu, Laëtitia Gimenez, Charly Kengne-Kuetche, Maryse Lapeyre Mestre, Julie Dupouy
Perceived risk of opioid use disorder secondary to opioid analgesic medication use by the general population in France. European journal of pain (London, England) 26 (3) (2022)
Camille Azam, Louis Buscail, Adrian Culetto, Maryse Lapeyre Mestre
Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety Reports. Drug safety 45 (3) (2022)
Clémentine Vabre, Yoann Zelmat, Martin Gauthier, Marie Pajiep, Cécile Conte, Maryse Lapeyre Mestre, Rosemary Dray-Spira, Mahmoud Zureik, Fabien Despas
Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories-A French population-based study using the French national health data system. American journal of hematology 97 (8) (2022)
Ondine Walter, Pierre Cougoul, Julien Maquet, Pablo Bartolucci, Maryse Lapeyre Mestre, Margaux Lafaurie, Guillaume Moulis
Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease. Blood 139 (26) (2022)
Anne Roussin, Thomas Soeiro, Charlotte Fouque, Emilie Jouanjus, Elisabeth Frauger, Nathalie Fouilhé, Michel Mallaret, Joëlle Micallef, Maryse Lapeyre Mestre, null null
Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data. British journal of clinical pharmacology 88 (8) (2022)
Bruno Revol, Maryse Lapeyre Mestre, Nathalie Fouilhé Sam-Laï, Emilie Jouanjus
Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database. British journal of clinical pharmacology 88 (11) (2022)
Yoann Zelmat, Cécile Conte, Pernelle Noize, Clémentine Vabre, Marie Pajiep, Margaux Lafaurie, Maryse Lapeyre Mestre, Fabien Despas
Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study. British journal of clinical pharmacology (2022)
Thanh Hang Chu, Manuela Rueter, Aurore Palmaro, Maryse Lapeyre Mestre
Potential inappropriate use of strong opioid analgesics in cancer outpatients during the last year of life in France and associated factors. British journal of clinical pharmacology (2021)
Fabrice Herin, Jerome Othenin, Emilie Jouanjus, Vanessa Rousseau, Michel Niezborala, Maryse Lapeyre Mestre
Evolution of medication consumption in a working environment in France: Results of the four waves of the "Drugs and Work" study (1986-2016). Pharmacoepidemiology and drug safety 30 (5) (2021)
Emilie Jouanjus, Valérie Gibaja, Florence Fabre, Maryse Lapeyre Mestre, null null
Medical prescription forms of opioid cough suppressants falsified by the patients before and after they switched from OTC to prescription-only in France. British journal of clinical pharmacology (2021)
Alexis Revet, Guillaume Moulis, Jean-Philippe Raynaud, Eric Bui, Maryse Lapeyre Mestre
Use of the French national health insurance information system for research in the field of mental health: Systematic review and perspectives. Fundamental & clinical pharmacology (2021)
Margaux Lafaurie, Julien Maquet, Bérangère Baricault, Charlotta Ekstrand, Christian F Christiansen, Marie Linder, Shahram Bahmanyar, Mette Nørgaard, Laurent Sailler, Maryse Lapeyre Mestre, Agnès Sommet, Guillaume Moulis
Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study. British journal of haematology 195 (3) (2021)
Joelle Perri-Plandé, Ghada Miremont-Salamé, Joëlle Micallef, Cameron Herman, Marie Baumevieille, Frédéric Abriat, Maryse Lapeyre Mestre, Françoise Haramburu, Amélie Daveluy, null null
A 13-Year National Monitoring Study to Assess Narcotic Prescriptions and Indications (2007-2019). Drug safety (2021)
Julien Maquet, Margaux Lafaurie, Ondine Walter, Laurent Sailler, Agnès Sommet, Maryse Lapeyre Mestre, Marc Michel, Guillaume Moulis
Epidemiology of autoimmune hemolytic anemia: A nationwide population-based study in France. American journal of hematology 96 (8) (2021)
Julien Maquet, Margaux Lafaurie, Laurent Sailler, Maryse Lapeyre Mestre, Guillaume Moulis
Correspondence on 'Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study'. Annals of the rheumatic diseases (2020)
Martin Gauthier, Cécile Conte, Aurore Palmaro, Emilie Patras De Campaigno, Sandra De Barros, Françoise Huguet, Guy Laurent, Maryse Lapeyre Mestre, Fabien Despas
Psychotropic drug initiation in patients diagnosed with chronic myeloid leukemia: a population-based study in France. Fundamental & clinical pharmacology 34 (5) (2020)
Amélie Daveluy, Joëlle Micallef, Paola Sanchez-Pena, Ghada Miremont-Salamé, Régis Lassalle, Clémentine Lacueille, Angela Grelaud, Virginie Corand, Caroline Victorri-Vigneau, Anne Batisse, Reynald Le Boisselier, Hélène Peyrière, Elisabeth Frauger, Maryse Lapeyre Mestre, Françoise Haramburu
Ten-year trend of opioid and nonopioid analgesic use in the French adult population. British journal of clinical pharmacology 87 (2) (2020)
Guilhem Tournaire, Cécile Conte, Aurore Perrot, Maryse Lapeyre Mestre, Fabien Despas
Vaccination during the First Diagnosis of Multiple Myeloma: A Cohort Study of the French National Health Insurance Database. Vaccines 8 (4) (2020)
Damien Driot, Emilie Jouanjus, Stéphane Oustric, Julie Dupouy, Maryse Lapeyre Mestre
Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France. British journal of clinical pharmacology 85 (6) (2019)
James S Floyd, Katarzyna M Bloch, Jennifer A Brody, Cyrielle Maroteau, Moneeza K Siddiqui, Richard Gregory, Daniel F Carr, Mariam Molokhia, Arthur L Beaudet, Joshua C Bis, Ammar Ahmed, Xuan Liu, Pär Hallberg, Qun-Ying Yue, Patrik K E Magnusson, Diane Brisson, Kerri L Wiggins, Alanna C Morrison, Etienne Khoury, Paul McKeigue, Bruno H Stricker, Maryse Lapeyre Mestre, Susan R Heckbert, Arlene M Gallagher, Hector Chinoy, Richard A Gibbs, Emmanuelle Bondon-Guitton, Russell Tracy, Eric Boerwinkle, Daniel Gaudet, Anita Conforti, Tjeerd van Staa, Colleen M Sitlani, Kenneth M Rice, Anke-Hilse Maitland-van der Zee, Mia Wadelius, Andrew P Morris, Munir Pirmohamed, Colin A N Palmer, Bruce M Psaty, Ana Alfirevic, null null
Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing. PloS one 14 (6) (2019)
Cécile Conte, Robert Bourrel, Fabien Despas, Maryse Lapeyre Mestre
Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region. Fundamental & clinical pharmacology 33 (3) (2019)
Sibylle de Germay, Manuela Rueter, François Montastruc, Vanessa Rousseau, Maryse Lapeyre Mestre, Jean-Louis Montastruc
Trends of atropinic (anticholinergic) exposure in the elderly: a 10-year analysis in the French EGB database. Fundamental & clinical pharmacology 33 (4) (2019)
Guillaume Moulis, Grégory Pugnet, Nathalie Costedoat-Chalumeau, Alexis Mathian, Gaëlle Leroux, Jonathan Boutémy, Olivier Espitia, Laurence Bouillet, Sabine Berthier, Jean-Baptiste Gaultier, Pierre-Yves Jeandel, Amadou Konaté, Arsenne Mekinian, Elisabeth Solau-Gervais, Benjamin Terrier, Daniel Wendling, Fanny Andry, Camille Garnier, Pascal Cathébras, Laurent Arnaud, Aurore Palmaro, Patrice Cacoub, Zahir Amoura, Jean-Charles Piette, Philippe Arlet, Maryse Lapeyre Mestre, Laurent Sailler
Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study. Annals of the rheumatic diseases 77 (8) (2018)
Emilie Jouanjus, Alice Falcou, Sylvie Deheul, Anne Roussin, Maryse Lapeyre Mestre
Detecting the diverted use of psychoactive drugs by adolescents and young adults: A pilot study. Pharmacoepidemiology and drug safety 27 (11) (2018)
Margaux Lafaurie, Liselotte Pochard, Clémence Lotiron, Laurent Molinier, Maryse Lapeyre Mestre, Emilie Jouanjus
Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University Hospital. Clinical drug investigation 38 (10) (2018)
Amélie Daveluy, Lucie Sauvaget, Angela Bastien, Maryse Lapeyre Mestre, Cédric Collin, Nathalie Richard, Françoise Haramburu
Tamper-resistant prescription forms for narcotics in France: Should we generalize them? Fundamental & clinical pharmacology 32 (5) (2018)
Emilie Jouanjus, Grégory Guernec, Maryse Lapeyre Mestre, null null
Medical prescriptions falsified by the patients: a 12-year national monitoring to assess prescription drug diversion. Fundamental & clinical pharmacology 32 (3) (2018)
Emilie Patras de Campaigno, Inès Kebir, Jean-Louis Montastruc, Manuela Rueter, Delphine Maret, Maryse Lapeyre Mestre, Brigitte Sallerin, Fabien Despas
Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBase. Drug safety 40 (12) (2018)
Sylvain Couderc, Maryse Lapeyre Mestre, Robert Bourrel, Carle Paul, Jean-Louis Montastruc, Agnès Sommet
Infectious risk of biological drugs vs. traditional systemic treatments in moderate-to-severe psoriasis: a cohort analysis in the French insurance database. Fundamental & clinical pharmacology 32 (4) (2018)
Liselotte Pochard, Julie Dupouy, Elisabeth Frauger, Adeline Giocanti, Joëlle Micallef, Maryse Lapeyre Mestre, null null
Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France. Fundamental & clinical pharmacology 32 (2) (2018)
Charlène Cool, Philippe Cestac, Cécile McCambridge, Laure Rouch, Philippe de Souto Barreto, Yves Rolland, Maryse Lapeyre Mestre
Reducing potentially inappropriate drug prescribing in nursing home residents: effectiveness of a geriatric intervention. British journal of clinical pharmacology 84 (7) (2018)
Joseph Rwagitinywa, Maryse Lapeyre Mestre, Robert Bourrel, Jean-Louis Montastruc, Agnès Sommet
Comparison of adherence to generic multi-tablet regimens vs. brand multi-tablet and brand single-tablet regimens likely to incorporate generic antiretroviral drugs by breaking or not fixed-dose combinations in HIV-infected patients. Fundamental & clinical pharmacology 32 (4) (2018)
Aurore Palmaro, Quentin Boucherie, Julie Dupouy, Joëlle Micallef, Maryse Lapeyre Mestre
Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies? Pharmacoepidemiology and drug safety 26 (5) (2017)
Aurore Palmaro, Martin Gauthier, Fabien Despas, Maryse Lapeyre Mestre
Identifying cancer drug regimens in French health insurance database: An application in multiple myeloma patients. Pharmacoepidemiology and drug safety 26 (12) (2017)
Mandy Prat, Hélène Derumeaux, Laurent Sailler, Maryse Lapeyre Mestre, Guillaume Moulis
Positive predictive values of peripheral arterial and venous thrombosis codes in French hospital database. Fundamental & clinical pharmacology 32 (1) (2017)
Camille Ponté, Christian Pi, Aurore Palmaro, Emilie Jouanjus, Maryse Lapeyre Mestre, null null
Early signal of diverted use of tropicamide eye drops in France. British journal of clinical pharmacology 83 (8) (2017)
Maryse Lapeyre Mestre
A Review of Adverse Outcomes Associated with Psychoactive Drug Use in Nursing Home Residents with Dementia. Drugs & aging 33 (12) (2017)
Emilie Patras de Campaigno, Emmanuelle Bondon-Guitton, Guy Laurent, François Montastruc, Jean-Louis Montastruc, Maryse Lapeyre Mestre, Fabien Despas
Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics. British journal of clinical pharmacology 83 (7) (2017)

Maryse Lapeyre Mestre.css-eqlu8i{font-size:small;padding-left:4px;} (Maryse Lapeyre-Mestre, Maryse Lapeyre-Mester)

Publication Activity (10 Years)

Top Topics

Top Venues

Maryse Lapeyre Mestre (Maryse Lapeyre-Mestre, Maryse Lapeyre-Mester)